Combined effect of GSTM1 gene deletion, GSTT1 gene deletion and MTHFR C677T mutation in male infertility by Đorđević Valentina et al.
Arch. Biol. Sci., Belgrade, 62 (3), 531-530, 2010  DOI:10.2298/ABS1003525D 
525 
COMBINED EFFECT OF GSTM1 GENE DELETION, GSTT1 GENE DELETION AND  
MTHFR C677T MUTATION IN MALE INFERTILITY 
VALENTINA ĐORĐEVIĆ
1, A. NIKOLIĆ
1, M. LJUJIĆ
1, A. NESTOROVIĆ
1, M. RISTANOVIĆ
2, 
C. TULIĆ
3 and D. RADOJKOVIĆ
1   
1Institute of Molecular Genetics and Genetic Engineering, Laboratory for Molecular Biology, 11000 Belgrade, Serbia 
2Institute of Human Genetics, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia 
3Institute of Urology, Clinical Center of Serbia, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia 
Abstract - The aim of the study was to investigate the association between the GSTM1 and GSTT1 gene deletion and 
MTHFR C677T mutation and male infertility. The study has encompassed 52 infertile and 56 fertile males. Genotype 
distributions of GSTM1 and GSTT1 gene deletions and the MTHFR C677T mutation did not differ significantly among 
the analyzed groups, however, a difference in distribution of certain genotype combinations was observed. The obtained 
results indicate that carriers of double GSTM1/GSTT1 deletion and the MTHFR 677CC genotype are at higher risk of 
infertility than carriers of any other combination of genotypes (OR 3.5, 95%CI 0.68-18.30). 
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INTRODUCTION 
Male infertility is a heterogeneous disorder, with 
various genetic and environmental factors that con-
tribute to the impairment of spermatogenesis. In 
spite of the attention that has been given to the 
research on mechanisms underlying male inferti-
lity, molecular events important for the onset and 
development of this disorder are still poorly under-
stood. The best characterized genetic causes of male 
infertility still remain microdeletions in the AZF 
(azoospermia factors) region of the Y chromosome 
and some mutations in the CFTR gene (Sertic et al., 
2001, Poongothai et al., 2009). Over the past couple 
of decades molecular genetics has discovered a large 
number of genes for which it has been proposed 
that, if mutated or deleted, can cause pathological 
changes in male reproductive system (Vogt et al, 
2004, Tüttelmann et al., 2007).  
One of the most important mechanisms invol-
ved in the homeostasis of male reproductive tissue 
is protection from oxidative stress, which male 
germ cells are highly susceptible to (Rao and Shaha, 
2000, Schuppe et al., 2000, Baker and Aitken, 2004). 
Glutathione S-transferases (GSTs) constitute a 
superfamily of ubiquitous, multifunctional enzymes 
which play a key role in phase II cellular 
detoxification and are generally considered to be 
‘‘antioxidant’’ enzymes (Rushmore and Pickett, 
1993). Several epidemiological studies have repor-
ted that the Glutathione S-transferases M1 and T1 
null genotypes (GSTM1 and GSTT1) that result in a 
lack of functional protein are correlated with an 
increased susceptibility to diseases associated with 
oxidative stress (Parl, 2005, Bolt and Their, 2006, 
Bohanec et al., 2009). The possible role in male 
infertility has been already suggested for these two 
gene variants, but published data are inconsistent 
(Chen et al., 2002, Aydos SE et al., 2009, Aydemir et 
al., 2007). 
The metabolism of folate is essential for proper 
cellular function and is also an important part of 
reproductive tissue homeostasis. Within the folate 
pathway, one of the most important enzymes is 
methylenetetrahydrofolate reductase (MTHFR). 
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functionality of the MTHFR protein, subsequently 
leading to hyperhomocysteinemia. It has been 
shown that severe MTHFR deficiency in male mice 
results in abnormal spermatogenesis and infertility 
(Kelly et al., 2005). These findings, in conjunction 
with clinical evidence, suggest an important role for 
MTHFR in spermatogenesis. However, the role of 
MTHFR C677T as a genetic risk factor for infertility 
remains unclear (Park et al., 2005, Stuppia et al., 
2003, Bezold et al., 2001, Ravel et al.,  2009). 
Compound genetic factors as a cause of male 
infertility were first observed in isolated cases 
(Black et al., 2000). The xenobiotic metabolism 
pathways in which MTHFR and glutathione S-
transferases are involved are closely functionally 
related and mutations in the genes encoding these 
enzymes were suggested to have a combined effect. 
The aim of the current study was to evaluate the 
association between the GSTM1 and GSTT1 deletion 
and MTHFR C677T mutation and male infertility. 
PATIENTS AND METHODS 
Subjects 
This study has encompassed 52 unrelated men 
presented with infertility associated with reduced or 
absent sperm counts. Written informed consent 
was obtained from all study patients and the 
investigation was approved by the hospital’s ethical 
committee. A spermogram was performed in order 
to determine the sperm density, and the diagnosis 
of azoospermia and severe oligozoospermia 
(<1x106 spermatozoa/mL) was made according to 
WHO guidelines (WHO, 1999). Previously perfor-
med cytogenetic analysis has shown normal ka-
ryotypes in all patients. The control group consisted 
of 56 age-matched men who had fathered at least 
one child which was confirmed through paternity 
testing.  
Genetic Analysis 
Genomic DNA was isolated from blood taken with 
sodium citrate by GFX Genomic Blood Purification 
Kit (GE Healthcare, Fairfield, USA) according to 
the manufacturer’s instructions.  
Detection of GSTM1 and GSTT1 gene deletions 
was performed by the multiplex PCR method (Arand 
et al, 1996). The following primer pairs were used: 5’-
GAACTCCCTGAAAAGCTAAAGC-3’ and 5’-
GTTGGGCTCAAATATACGGTGG-3’ for GSTM1 
and 5’-TTCCTTACTGGTCCTCACATCTC-3’ and 
5’-CAGCTGCATTTGGAAGTGCTC-3’ for GSTT1. 
Part of the albumin gene was used as an internal 
amplification control and was amplified with the 
following primers: 5’-CAACTTCATCCACGTTCA 
CC-3’ and 5’-GAAGAGCCAAGGACAGGTAC-3’. 
The amplification was performed in the following 
mixture (total volume 30 μL): 50 mM Tris-HCl pH 9, 
0.1% Triton X-100, 5 mM MgCl2, 0.2 mM each dNTP 
(dATP, dTTP, dGTP and dCTP), 10 pmol of each 
primer for GSTM1 and albumin, 12 pmol of each 
primer for GSTT1 and 1 U of Taq polymerase 
(Applied Biosystems, Foster City, USA) with 
approximately 800 ng of isolated DNA. The reaction 
mixtures were first subjected to initial denaturation at 
94°C for 10 min; 35 cycles consisting of denaturation 
at 94°C for 1 min, primer annealing at 58°C for 30 s 
and DNA extension at 72°C for 45 s; the final DNA 
extension was at 72°C for 10 min. The PCR reactions 
were performed in a Mastercycler gradient apparatus 
(Eppendorf). The products of the multiplex PCR 
(GSTM1-215bp, GSTT1-480 bp and albumine-350 
bp) were separated by horizontal electrophoresis on 
2% agarose gels and visualized by ethidium-bromide. 
Both GSTM1 and GSTT1 products were categorized 
as having either a non-null or null (homozygous 
deletion) genotype. 
Detection of the MTHFR C677T mutation was 
performed by PCR-RFLP analysis (Djordjevic et al, 
2005). We used the following primer pairs: 5'- TGA 
AGG AGA AGG TGT TG CGG GA -3' and 5'- 
AGG ACG GTG CGG TGA GAG TG -3' (Frost et 
al, 1995). The amplification was performed in a 
mixture (25 μL final volume) containing 50 mM 
KCl, 100mM Tris-HCl, pH 9.0, 0.1% Triton X-100, 
each dNTP (dATP, dTTP, dGTP and dCTP), 5 mM 
MgCl2, 10 pmol of forward and reverse primers and 
1 μL of whole blood. The thermal cycle profile was   GENES EFFECT IN MALE INFERTILITY  527 
 
5 cycles (98ºC for 3 min and 55ºC for 3 min), to as-
sure complete denaturation of the DNA. One unit 
Taq polymerase (AppliedBiosystems, Foster City, 
USA) was added at 50ºC and after 5 min, 35 cycles 
consisting of denaturation at 94ºC for 30 s, 
annealing at 61ºC for 30 s and polymerization at 
72ºC for 30 s were applied. The final extension of 
PCR products was performed at 72ºC for 10 min. 
The PCR reactions were performed in a Master-
cycler gradient apparatus (Eppendorf). Polymor-
phic 677C and 677T alleles were identified by 
restriction enzyme cleavage of the PCR product 
using the restriction enzyme HinfI (New England, 
BioLabs). Digestion products were analyzed by 
electrophoresis on a 10% polyacrylamide gel, follo-
wed by silver staining of the gels.
 
Statistical analysis 
Statistical analysis was performed using SPSS 10.0. 
For the calculated frequencies of each allele, 
genotype and combination of genotypes two sta-
tistical parameters were determined – p value and 
OR value, with 95%CI. Values p ≤  0.05 were consi-
dered statistically significant. 
RESULTS 
Detection of GSTM1 deletion, GSTT1 deletion 
and MTHFR C677T mutation was performed in 
52 infertile men and 56 fertile men as control 
group. 
Deletion of the GSTM1 gene was detected in 29 
patients (56%) and in 27 controls (48%), while the 
GSTT1 gene was deleted in 20 patients (38%) and 
in 15 controls (27%). (Table 1). Both deletions were 
present in 12 patients (23%) and in 6 controls 
(11%). 
Mutation MTHFR C677T was present with a 
frequency of 34.6% (36 out of 104 analyzed 
chromosomes) in infertile men and a frequency of 
35.7% (40 out of 112 analyzed chromosomes) in 
controls. Among the 52 patients, 22 were 
homozygous for normal allele (42%), 24 were 
heterozygous (46%) and 6 were homozygous for the 
mutated allele (12%). Among the 56 controls, 23 
were homozygous for the normal allele (41%), 26 
were heterozygous (46%) and 7 were homozygous 
for the mutated allele (13%) (Table 1). 
Table 1. Distribution of MTHFR, GSTM1 and GSTT1 genotypes in patients and controls
MTHFR 
C677T 
GSTM1/ 
GSTT1 
No. of 
patients 
% No.  of 
controls 
% OR p   
N / N  + / + 
+ / - 
- / + 
- / - 
8 
1 
7 
6 
15.4 
1.9 
13.5 
11.5 
10 
3 
8 
2 
17.7 
5.4 
14.4 
3.6 
0.8 
0.3 
0.9 
3.5 
0.80 
0.62 
1.00 
0.15 
0.60-2.31 
0.04-3.44 
0.31-2.78 
0.68-18.30 
M / N  + / + 
+ / - 
- / + 
- / - 
5 
5 
9 
5 
9.6 
9.6 
17.3 
9.6 
10 
4 
9 
3 
17.9 
7.1 
16.1 
5.4 
0.4 
1.4 
1.1 
1.9 
0.27 
0.74 
1.00 
0.48 
0.16-1.54 
0.35-5.46 
0.40-3.01 
0.43-8.29 
M / M  + / + 
+ / - 
- / + 
- / - 
2 
2 
1 
1 
3.8 
3.8 
1.9 
1.9 
0 
2 
4 
1 
 
3.6 
7.1 
1.8 
 
1.1 
0.3 
1.4 
0.23 
1.00 
0.36 
1.00 
 
0.15-7.96 
0.03-2.36 
0.07-17.70 
 
N-wild type allele, M-mutant allele, No-number, -null, +present 528 V.  ĐORĐEVIĆ  ET AL. 
Regarding the presence of combined genotypes, 
deletion of the GSTM1 gene was present in 2 (3.8%) 
carriers of the MTHFR 677TT genotype in patients, 
and in 5 individuals (8.9%) in the control group. In 
combination with the 677CT genotype, this deletion 
was present in 14 (26.9%) patients and 12 (21.4%) 
control individuals. A wild-type MTHFR genotype 
and GSTM1 gene deletion were found in 13 (25%) 
patients and 10 (17.8%) subjects in the control group. 
The GSTT1deletion/MTHFR677TT haplotype was 
present in three patients (5.8%) vs. three controls 
(5.4%); the GSTT1deletion/MTHFR677CT haplotype 
was observed in 10 patients (19.3%) vs. 7 controls 
(12.5%), and the GSTT1deletion/MTHFR677CC hap-
lotype in 7 patients (13.5%) vs. 5 control subjects 
(8.9%). Among 12 patient carriers of both GST 
deletions we found in 1.9% of MTHFR677TT, 9.6% of 
MTHFR677CT and 11.5% of MTHFR677CC geno-
types. This was the case in 1.8%, 5.4% and 3.6% of 
control subjects, respectively (Table 1). No significant 
differences were observed for any genotype combi-
nation. 
DISCUSSION 
Male infertility is a heterogeneous disorder, with 
various genetic and environmental factors 
contributing to the impairment of spermatogenesis. 
In this study we analyzed three different genes 
(GSTM1, GSTT1 and MTHFR) with important 
roles in pathways of reactive oxygene species. We 
compared the distributions of GSTM1 and GSTT1 
gene deletion and MTHFR C677T mutation among 
52 men diagnosed with a severe spermatogenic 
defect and 56 controls whose fertility was confir-
med through paternity testing. 
Deletions of GSTM1 and GSTT1 genes probably 
cause an imbalance of oxidants and antioxidants in 
the reproductive tissue that could play a role in the 
etiology of male infertility. In our patients, the 
prevalence of GSTM1 and GSTT1 deletions did not 
considerably differ when compared to the control 
group (15.4% and 32.7% vs.16.1% and 37.5%, 
respectively). Increased risk of infertility was ob-
served in carriers of both GST deletions (OR value 
2.5) in comparison to carriers of GSTM1 (OR value 
0.8) and GSTT1 deletion (OR value 0.9). Although 
the double GSTM1/GSTT1 deletion was two times 
higher in patients than in the controls (23% vs. 11%), 
this difference was not statistically significant 
(p=0.12). Our results are in agreement with the study 
of Schuppe who observed the GSTM1/T1 deletion as 
the most frequent genotype in individuals with an 
abnormal spermogram (Schuppe et al., 2000). On the 
other hand, results obtained in the study of 
Polonikov reported the association of normal GSTT1 
gene genotype with the increased risk of idiopathic 
male infertility (Polonikov et al., 2010). 
The involvement of MTHFR in spermatogenesis 
is believed to be through the regulation of DNA 
methylation (Friso et al., 2002, Khazamipour et al., 
2009). It also affects the oxidative status of the 
reproductive tissue, since homocysteine can mediate 
DNA damage in spermatozoa (Forges et al., 2007). In 
our study, the distribution of the MTHFR C677T 
polymorphism among patients and controls was si-
milar (Table 1). This is consistent with previous fin-
dings that do not support an association between the 
MTHFR 677T allele and male infertility (Stuppia et 
al., 2003, Ravel et al., 2009). However, meta-analyses 
of Tüttelmann and coworkers revealed significant 
associations between C677T polymorphism and ma-
le infertility (OR 1.39, 95%CI 1.15-2.69, P=0.0006) 
(Tüttelmann et al., 2007).  
A recent study which has indicated the in-
teraction between MTHFR and GSTM1 showed that 
subjects who are carriers of a 677CT or 677TT ge-
notype of the MTHFR gene and who carry a func-
tional copy of GSTM1 have a significantly higher risk 
of infertility than subjects who carry the wild-type 
genotype for both genes (Paracchini et al., 2006). We 
also found that interaction between MTHFR and 
GSTs played a role in the etiology of infertility, but in 
the opposite way. We observed the highest risk of 
infertility (OR=3.5, CI95% 0.68-18.29) in patients 
homozygous for MTHFR normal allele (677CC 
genotype) who at the same time carried both GSTM1 
and GSTT1 deletions. In addition, the risk was lower 
in the presence of one mutated MTHFR allele 
(OR=1.9, CI95% 0.43-8.29).    GENES EFFECT IN MALE INFERTILITY  529 
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Fig. 1.  Schematic representation of metabolic pathways in-
volving GST and MTHFR 
The possible explanation for the combined ef-
fect of mutations in GST genes and the MTHFR 
gene could be that the enzymes encoded by these 
genes are closely related in the metabolic pathways 
involved in protection from oxidative stress (Figure 
1). Homocysteine can serve not only as a precursor 
of S-adenosylmethionine (SAM) in the methylation 
pathway, but also as a precursor of glutathione 
required for various detoxification processes (Hoey 
et al., 2009).  
It has been speculated that in mutant MTHFR 
C677T homozygotes who carry the GSTM1 de-
letion, higher glutathione levels that have a positive 
effect on SAM synthetase activity could lead to an 
increase in methylation, thus compensating for the 
lack of methylation due to the decrease in methio-
nine synthesis (Castagna et al., 1995, Paracchini et 
al., 2005). Our findings that the homozygote 
carriers of mutant MTHFR C677T and double 
GSTM1/GSTT1 deletion are not at risk of infertility 
could be explained by this mechanism. In such a 
combination of genotypes, excessive homocysteine 
levels could induce the production of higher 
amounts of glutathione, which can compensate for 
the absence of the GSTM1 and GSTT1 detoxi-
fication function by taking part in other detoxi-
fication processes in cell.  
To summarize, our study has shown that the 
combination of GSTM1 and GSTT1 deletion and 
MTHFR C677T could represent a complex genetic 
risk factor predisposing male infertility. We 
speculate that the GSTM1/GSTT1 gene deletion 
represents an initial risk factor. On the other hand, 
the MTHFR C677T mutation can act as a protective 
factor if GSTM1 and GSTT1 are deleted. Although 
the results of the present study are preliminary and 
should be verified in larger groups of infertile 
males, they point to the possible role of the 
combined effect of mutations in GSTM1, GSTT1 
and MTHFR genes in the etiology of male 
infertility.  
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